Last Modified: May 9, 2013
Dates: September 27, 2013
Location: Chicago, IL
Sponsoring Group: The American Society of Hematology
Web Page URL: www.hematology.org/calendar_CHC2013
Topics Covered: If you see patients with non-malignant hematologic disorders infrequently and would like to update your core knowledge of hematology, then this refresher course is for you. The half-day program will cover commonly encountered clinical problems that arise in everyday practice and require the expertise of a hematologist. It will focus on non-malignant hematology and will use case-based presentations and interactive discussions. The hands-on course will be led by faculty familiar with consultative practice issues.
Objectives: The goal of the Consultative Hematology Course is to update attendees' core knowledge of non-malignant hematology disorders and will cover commonly encountered clinical problems that arise in everyday practice and require the expertise of a hematologist.
Who Should Attend: Hematologist-Oncologists, Oncologists
Registration Information: Registration information can be found on www.hematology.org/calendar_CHC2013
Continuing Education: Yes
Dec 11, 2013 - Many patients with myeloproliferative neoplasms without mutations in the Janus kinase 2 gene (JAK2) or in the thrombopoietin receptor gene (MPL) have mutations in the CALR gene encoding calreticulin, according to two studies published online Dec. 10 in the New England Journal of Medicine. The research was published to coincide with presentation at the annual meeting of the American Society of Hematology, held from Dec. 7 to 10 in New Orleans.
Dec 14, 2011
Nov 27, 2014
Nov 27, 2014
Jan 3, 2014
Dec 3, 2013